Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Current Deferred Revenue: 2009-2025

Historic Current Deferred Revenue for Gyre Therapeutics (GYRE) over the last 11 years, with Sep 2025 value amounting to $58,000.

  • Gyre Therapeutics' Current Deferred Revenue rose 61.11% to $58,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $58,000, marking a year-over-year increase of 61.11%. This contributed to the annual value of $61,000 for FY2024, which is 56.41% up from last year.
  • Per Gyre Therapeutics' latest filing, its Current Deferred Revenue stood at $58,000 for Q3 2025, which was up 107.14% from $28,000 recorded in Q1 2025.
  • In the past 5 years, Gyre Therapeutics' Current Deferred Revenue registered a high of $2.0 million during Q2 2021, and its lowest value of $28,000 during Q1 2025.
  • In the last 3 years, Gyre Therapeutics' Current Deferred Revenue had a median value of $39,000 in 2023 and averaged $44,857.
  • Examining YoY changes over the last 5 years, Gyre Therapeutics' Current Deferred Revenue showed a top increase of 517.58% in 2021 and a maximum decrease of 88.40% in 2021.
  • Gyre Therapeutics' Current Deferred Revenue (Quarterly) stood at $230,000 in 2021, then crashed by 36.96% to $145,000 in 2022, then slumped by 73.10% to $39,000 in 2023, then soared by 56.41% to $61,000 in 2024, then soared by 61.11% to $58,000 in 2025.
  • Its Current Deferred Revenue was $58,000 in Q3 2025, compared to $28,000 in Q1 2025 and $61,000 in Q4 2024.